We evaluated the usefulness of YAP, TEAD4, SMAD2, SMAD3, H2A.X, ALD1A1, CD71, TKT and TKTL1 as diagnostic or prognostic markers in patients with ovarian cancer. This evidence concerns the gene SMAD2 and ovarian carcinoma.